4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000055
Chief Financial Officer sold 3,195 shares at $14.97 ($47,832)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-09-09 | Sale 10b5-1 | −3,195 | $14.97 | $47,832 | 76,486 | D |
| Open-market sales · 3,195 sh · avg $14.97 · $47,832 | |||||||
Loading xslF345X05/wk-form4_1726000485.xml…